Literature DB >> 18195119

Treatment of Anderson-Fabry disease.

Ales Linhart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18195119     DOI： 10.1136/hrt.2006.113886

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  3 in total

1.  Effects of switching from agalsidase Beta to agalsidase alfa in 10 patients with anderson-fabry disease.

Authors:  A Pisani; L Spinelli; B Visciano; I Capuano; M Sabbatini; E Riccio; G Messalli; M Imbriaco
Journal:  JIMD Rep       Date:  2012-10-21

2.  Role of cardiac MRI in evaluating patients with Anderson-Fabry disease: assessing cardiac effects of long-term enzyme replacement therapy.

Authors:  G Messalli; M Imbriaco; G Avitabile; R Russo; D Iodice; L Spinelli; S Dellegrottaglie; F Cademartiri; M Salvatore; A Pisani
Journal:  Radiol Med       Date:  2011-07-09       Impact factor: 3.469

3.  Endomyocardial biopsies in patients with left ventricular hypertrophy and a common Chinese later-onset Fabry mutation (IVS4 + 919G > A).

Authors:  Ting-Rong Hsu; Shih-Hsien Sung; Fu-Pang Chang; Chia-Feng Yang; Hao-Chuan Liu; Hsiang-Yu Lin; Chun-Kai Huang; He-Jin Gao; Yu-Hsiu Huang; Hsuan-Chieh Liao; Pi-Chang Lee; An-Hang Yang; Chuan-Chi Chiang; Ching-Yuang Lin; Wen-Chung Yu; Dau-Ming Niu
Journal:  Orphanet J Rare Dis       Date:  2014-07-01       Impact factor: 4.123
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.